Makoto Sugaya

Clinical End Points and Response Criteria in Mycosis Fungoides and Sézary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer

Elise A. Olsen, Sean Whittaker, Youn H. Kim et al. · Journal of Clinical Oncology · 2011 · 641 citations · Full text

Immunodeficiencies, Immunology, Clinical End Points +17

Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model

Julia Scarisbrick, H. Miles Prince, Maarten H. Vermeer et al. · Journal of Clinical Oncology · 2015 · 407 citations · Full text

Langerhans cells utilize CD1a and langerin to efficiently present nonpeptide antigens to T cells

Robert E. Hunger, Peter A. Sieling, María Teresa Ochoa et al. · Journal of Clinical Investigation · 2004 · 267 citations

T-regulatory Cell, Immunology, Antigen Processing +16

Langerhans cells utilize CD1a and langerin to efficiently present nonpeptide antigens to T cells

Robert E. Hunger, Peter A. Sieling, María Teresa Ochoa et al. · Journal of Clinical Investigation · 2004 · 254 citations · Full text

R5 HIV productively infects Langerhans cells, and infection levels are regulated by compound<i>CCR5</i>polymorphisms

Tatsuyoshi Kawamura, Forrest O. Gulden, Makoto Sugaya et al. · Proceedings of the National Academy of Sciences · 2003 · 190 citations · Full text